Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBIAT: 2009-2011

Historic EBIAT for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' EBIAT fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$116.2 million, marking a year-over-year decrease of 14.19%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • As of Q4 2011, Lexicon Pharmaceuticals' EBIAT stood at -$33.8 million, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' EBIAT peaked at -$22.7 million during Q3 2009, and registered a low of -$33.8 million during Q4 2011.
  • In the last 3 years, Lexicon Pharmaceuticals' EBIAT had a median value of -$26.1 million in 2010 and averaged -$26.2 million.
  • The largest annual percentage gain for Lexicon Pharmaceuticals' EBIAT in the last 5 years was 5.12% (2011), contrasted with its biggest fall of 47.16% (2011).
  • Quarterly analysis of 3 years shows Lexicon Pharmaceuticals' EBIAT stood at -$23.5 million in 2009, then rose by 2.31% to -$23.0 million in 2010, then plummeted by 47.16% to -$33.8 million in 2011.
  • Its EBIAT was -$33.8 million in Q4 2011, compared to -$26.1 million in Q3 2011 and -$26.6 million in Q2 2011.